Hermetica Superfood Encyclopedia
The Short Answer
Bisabolol is a naturally occurring sesquiterpenoid alcohol found primarily in German chamomile (Matricaria chamomilla) and candeia tree oil. It exerts anti-inflammatory and skin-protective effects largely through activation of peroxisome proliferator-activated receptor gamma (PPAR-γ) and suppression of pro-inflammatory cytokine cascades.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordbisabolol benefits
Synergy Pairings5
Bisabolol — botanical close-up
Health Benefits
Origin & History
Natural habitat
Bisabolol is a naturally occurring sesquiterpene alcohol primarily sourced from German chamomile (Matricaria recutita) essential oils, as well as from the candeia tree (Vanillosmopsis erythropappa) and cotton gin trash. It is extracted through steam distillation of flowers or stems followed by purification, yielding a viscous, colorless to pale yellow oil that is commercially available at >95% α-bisabolol purity.
“α-Bisabolol-rich chamomile essential oil has been documented in European traditional medicine since the Middle Ages (~10th century monastic texts) for treating skin inflammation, wounds, and gastrointestinal issues. In Ayurvedic and Unani systems, chamomile species have been used for centuries to treat digestive inflammation and allergies, while Native South Americans traditionally used candeia tree oil for skin soothing applications.”Traditional Medicine
Scientific Research
Human clinical evidence for bisabolol is limited, with most data from topical formulations; a randomized clinical trial (NCT05022108) is currently evaluating 1% α-bisabolol gel for urticaria but results are not yet published. A small clinical investigation (PMID: 29025339) showed topical α-bisabolol improved inflammatory skin conditions in 20-30 participants over 4 weeks. No large-scale RCTs or meta-analyses for systemic use exist; most evidence comes from preclinical models including DSS colitis (PMID: 35465355) and asthma studies (PMID: 40765560).
Preparation & Dosage
Traditional preparation
Topical: 0.5-1% in creams for skin inflammation; 1% gel being studied for urticaria (applied 2-3x daily). Oral: No established human doses; preclinical studies used 25 mg/kg in rats. Commercial products standardize to >95% α-bisabolol purity. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Bisabolol is a naturally occurring monocyclic sesquiterpene alcohol (C15H26O, molecular weight 222.37 g/mol), not a food ingredient and thus carries no conventional macronutrient or micronutrient profile. It contains no protein, carbohydrates, dietary fiber, or minerals. As a lipophilic bioactive compound, its primary characterization is as a terpenoid secondary metabolite. It occurs in two enantiomeric forms: α-bisabolol (the biologically active form, predominantly derived from chamomile, Matricaria chamomilla, at concentrations of 10–25% of the essential oil) and β-bisabolol. Synthetic (racemic) bisabolol is also widely used. Bioavailability is governed by its lipophilic nature (logP ≈ 4.0–4.5), meaning percutaneous absorption is favorable for topical applications, with in vitro skin penetration studies showing meaningful dermal uptake through stratum corneum partitioning. Oral bioavailability data in humans is limited, but animal studies suggest hepatic first-pass metabolism is significant. When present in chamomile essential oil, bisabolol co-occurs with chamazulene, apigenin, and bisabolol oxides A and B, though these are distinct compounds. No caloric value, vitamin content, or mineral content is attributable to bisabolol itself. It is typically used at functional concentrations of 0.1–1.0% w/w in topical formulations.
How It Works
Mechanism of Action
Bisabolol activates PPAR-γ, a nuclear receptor that downregulates NF-κB signaling, thereby reducing transcription of pro-inflammatory cytokines including IL-6, IL-1β, and TNF-α. It also inhibits 5-lipoxygenase and cyclooxygenase pathways, limiting leukotriene and prostaglandin synthesis that drive skin and mucosal inflammation. Additionally, bisabolol enhances skin permeability by disrupting intercellular lipid bilayers in the stratum corneum, which both improves drug delivery and reduces irritant-induced barrier disruption.
Clinical Evidence
Clinical evidence for bisabolol is limited but promising in topical applications. A small controlled study of 20–30 participants demonstrated measurable reductions in skin erythema and irritation scores using topical bisabolol formulations (PMID: 29025339). Preclinical colitis models have shown significant suppression of IL-6, IL-1β, and TNF-α through PPAR-γ activation, though these findings await confirmation in human gastrointestinal trials (PMID: 35465355). Overall, the evidence base is predominantly preclinical and small-scale, making it premature to draw firm conclusions about systemic oral supplementation efficacy.
Safety & Interactions
Bisabolol has a well-established topical safety record and is classified as generally recognized as safe (GRAS) by the Cosmetic Ingredient Review panel at concentrations up to 0.5–1% in cosmetic formulations. Allergic contact dermatitis is rare but possible, particularly in individuals with existing sensitivity to Asteraceae/Compositae family plants such as chamomile, ragweed, or chrysanthemum. No significant drug interactions have been formally documented in human studies, though its PPAR-γ agonist activity theoretically warrants caution when combined with insulin sensitizers or thiazolidinedione-class drugs. Systemic oral supplementation safety data in pregnant or lactating women is insufficient, and use in these populations is not recommended without medical supervision.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
α-Bisabololalpha-Bisabolol(-)-α-BisabololLevomenolDragosantolBisabolol oxideChamomile alcoholα-Bisabolol alcohol2-[4-Methyl-3-cyclohexen-1-yl]propan-2-ol
Frequently Asked Questions
What is bisabolol used for in supplements?
Bisabolol is primarily used in supplements for its anti-inflammatory and gastroprotective properties, with preclinical evidence showing reduced cytokines IL-6, IL-1β, and TNF-α in colitis models via PPAR-γ activation. It also appears in topical formulations targeting skin irritation, redness, and post-procedure recovery. Oral supplement use remains less studied than topical application, and robust human clinical trials are still needed.
Is bisabolol the same as chamomile extract?
Bisabolol is not identical to chamomile extract but is one of the primary bioactive sesquiterpenoids isolated from German chamomile (Matricaria chamomilla). Chamomile extract is a complex mixture containing bisabolol, bisabolol oxides, apigenin, and other flavonoids, each contributing different pharmacological effects. Standardized bisabolol supplements isolate the alpha-bisabolol enantiomer to deliver more consistent anti-inflammatory activity compared to whole chamomile preparations.
What is the recommended dosage of bisabolol?
No universally established oral dosage for bisabolol supplementation has been validated in large-scale human clinical trials. Topical cosmetic formulations typically use concentrations of 0.1–1.0% by weight, which have demonstrated skin-calming effects in studies. For oral use, preclinical models have used doses in the range of 25–100 mg/kg in rodents, but direct human equivalent dosing has not been formally determined through clinical dose-ranging studies.
Can bisabolol cause any side effects?
Bisabolol is generally well-tolerated topically, with adverse effects being uncommon and typically limited to contact dermatitis in individuals sensitive to Asteraceae family plants. Systemic side effects from oral supplementation are not well-characterized due to limited human trial data. Theoretically, its PPAR-γ agonist activity at high doses could influence lipid metabolism or insulin sensitivity, but no confirmed clinical cases of systemic side effects have been published.
Does bisabolol have anti-inflammatory properties supported by research?
Yes, bisabolol's anti-inflammatory properties are supported by preclinical research demonstrating activation of PPAR-γ and subsequent downregulation of NF-κB-driven cytokines including IL-6, IL-1β, and TNF-α in colitis models (PMID: 35465355). It also inhibits 5-lipoxygenase and cyclooxygenase enzymes, reducing leukotriene and prostaglandin production. While these mechanisms are mechanistically compelling, confirmation through randomized controlled human trials is still needed before strong clinical anti-inflammatory claims can be made.
Is bisabolol safe during pregnancy and breastfeeding?
Limited clinical safety data exists for bisabolol supplementation during pregnancy and breastfeeding, so it is generally recommended to avoid supplemental use during these periods unless under medical supervision. While bisabolol is present in chamomile tea consumed traditionally, concentrated supplement forms have not been adequately studied in pregnant or nursing populations. Consulting with a healthcare provider before use is advisable in these situations.
Does bisabolol interact with common medications?
Bisabolol may potentially interact with medications metabolized by CYP3A4 enzymes and those affecting blood clotting, though clinical evidence in humans is sparse. Its PPAR-γ activation suggests possible interactions with diabetes medications, requiring caution in patients taking antidiabetic drugs. Any individual taking prescription medications should consult their healthcare provider before adding bisabolol supplementation.
What is the clinical evidence quality for bisabolol's health benefits?
Most bisabolol research consists of preclinical (laboratory and animal) studies showing promising anti-inflammatory and potential anticancer effects through mechanisms like PPAR-γ activation and cytokine reduction. Only a small number of clinical trials exist in humans, primarily involving topical skin applications with modest sample sizes (20-30 participants). Larger, well-designed human clinical trials are needed to definitively establish efficacy for oral supplementation and internal health benefits.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w bisabolol curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
